| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.3 | 2e-09 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.28 | 1e-07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-06 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.24 | 4e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.24 | 5e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 5e-06 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-05 |